Summons Executed in Zofran Lawsuit Alleging Birth Defects

Attorneys representing clients nationwide in Zofran lawsuits provide an update on one of the Onder Law Firm's pending Zofran lawsuits for birth defect allegations.

Tuesday, April 21, 2015 - Attorneys for Zofran lawsuits report progress on one of the first zofran birth defects lawsuits that have been filed nationwide, which they now have pending in U.S. District Court in Northern Alabama.* According to these Zofran lawyers, a summons order has been acknowledged by the defendant, GlaxoSmithKline.

"Normally, the minutiae of a new case does not interest the general public, but in the case of Zofran lawsuits, none have advanced yet to provide a precedent for how these cases might be resolved. We offer Zofran lawsuit news and updates in order to allow the general public information about birth defect claims. Persons and families whose child was born with birth defects are contacting our firm on a daily basis to learn more about their legal rights," explained attorney James Onder.

GlaxoSmithKline, the defendant, has already resolved federal litigation with the U.S. Department of Justice regarding its promotion of Zofran for use in pregnant women, according to court documents. Zofran has never been approved for this indication, nor has it been adequately tested, according to court documents. The lawsuit alleges that promoting the drug for pregnant mothers, an off-label use, constitutes negligence on the part of the company that resulted in serious harm to children, according to court documents.

The Alabama lawsuit was filed by a mother who alleges her son‘s myriad birth defects and health complications are linked to the fact that she took the anti-nausea medication Zofran during her pregnancy, according to the complaint, an official court document. Starting at birth, the child has suffered from a range of physical and developmental disabilities and delays, including cleft pallet, extra digits, kidney problems, seizures, and other health problems, according to court documents. The plaintiff alleges her son cannot speak as a result of Zofran exposure in utero, and that he has experienced a decrease in his enjoyment of life, according to court documents.

Attorneys handling national zofran lawsuits for the Onder Law Firm are currently offering no-cost, no-obligation Zofran lawsuit case review for parents and families whose child was born with birth defects and was possibly exposed to Zofran during prenatal development. These Zofran attorneys believe persons who meet this description may be entitled to compensation through filing a Zofran lawsuit. Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm‘s Zofran lawyers have committed their significant resources to providing expert legal representation to women, children and families who believe they may have grounds to file Zofran lawsuits.

The Onder Law Firm welcomes Zofran lawsuit case inquiries from law firms in regards to handling them or working as co-counsel.

*Julie Hunter and Talon Hunter v GlaxoSmithKline et al, Case No. 2:15-cv-00544-JEO, U.S. District Court, Northern District of Alabama, filed 4/1/15

Other Zofran Birth Defects Lawsuit Attorney News Releases: